Is Bifidobacterium a more effective probiotic therapy than Lactobacillus for patients with irritable bowel syndrome?

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 2, Issue 7, 2005, Pages 304-305

  Furrie, Elizabeth ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Bifidobacterium; Irritable bowel syndrome; Lactobacillus; Probiotic

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; PLACEBO; PROBIOTIC AGENT;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; BIFIDOBACTERIUM LONGUM INFANTIS; BLOATING; CLINICAL FEATURE; CYTOKINE PRODUCTION; FECES ANALYSIS; HUMAN; INTESTINE FLORA; INTESTINE FUNCTION; IRRITABLE COLON; LACTOBACILLUS SALIVARIUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; QUESTIONNAIRE; SHORT SURVEY; STATISTICAL SIGNIFICANCE; VISUAL ANALOG SCALE;

EID: 23344442401     PISSN: 17434378     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpgasthep0219     Document Type: Short Survey

References (5)

1. Spiller R (2004) Probiotics: an ideal anti-inflammatory treatment for IBS? Gastroenterology 128: 783-785
2. Hart AL et al. (2004) Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 53: 1602-1609
3. Christensen HR et al. (2002) Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immun 168: 171-178
4. Ibnou-Zekri N et al. (2003) Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect Immun 71: 428-436
5. Kalliomaki M et al. (2001) Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357: 1076-1079